MétaCan
Menu
Back to cohort
Record W4289834004 · doi:10.14745/ccdr.v48i78a08

Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants

2022· article· en· W4289834004 on OpenAlexafffundvenue
Dorothy Moore, Angela Sinilaité, April Killikelly

Bibliographic record

VenueCanada Communicable Disease Report · 2022
Typearticle
Languageen
FieldMedicine
TopicRespiratory viral infections research
Canadian institutionsPublic Health Agency of Canada
FundersCenters for Disease Control and PreventionCanadian Armed ForcesAssociation of Medical Microbiology and Infectious Disease CanadaAssociation des pharmaciens du CanadaPublic Health AgencyPublic Health Agency of Canada
KeywordsPalivizumabStatement (logic)Advisory committeeMedicineImmunizationRespiratory systemBronchiolitisPediatricsVirologyIntensive care medicineVirusImmunologyPolitical scienceInternal medicinePublic administrationLawImmune system

Abstract

fetched live from OpenAlex

Background: ). The National Advisory Committee on Immunization (NACI) published a statement for PVZ use in 2003. The purpose of this article is to update previous NACI recommendations for the use of PVZ, taking into consideration recent data on RSV burden of illness, effectiveness of PVZ in infants at risk of more severe RSV disease and economic implications of PVZ use. Methods: The NACI Working Group and external experts performed systematic literature reviews on three topics to support updated NACI guidance: 1) RSV burden of disease; 2) PVZ effectiveness; and 3) cost effectiveness of PVZ prophylaxis. Full details and results are presented in the statement and supporting documents. Results: Respiratory syncytial virus hospitalization (RSVH) rates are highest in children younger than one year of age and especially in the first two months of life. In various populations of infants at risk of severe RSV infection, PVZ prophylaxis is associated with reductions of 38%-86% in the risk of RSVH. Only rare cases of anaphylaxis have been reported after decades of use. Palivizumab is expensive and only cost-saving in rare scenarios. Conclusion: Updated NACI recommendations on use of PVZ for the prevention of complications of RSV in infants are now available.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.030
metaresearch head score (Gemma)0.082
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.987
Threshold uncertainty score0.529

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0300.082
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0080.008
Science and technology studies0.0020.001
Scholarly communication0.0030.001
Open science0.0040.002
Research integrity0.0050.005
Insufficient payload (model declined to judge)0.0130.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.103
GPT teacher head0.364
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2022
Admission routes3
Has abstractyes

Explore more

Same venueCanada Communicable Disease ReportSame topicRespiratory viral infections researchFrench-language works237,207